Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
42.62
1.07 (2.58%)
At close: Aug 15, 2025, 3:59 PM
43.44
1.92%
After-hours: Aug 15, 2025, 05:03 PM EDT

Kymera Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-13.49 -10.11 -8.87 -31.09
PEG Ratio
-0.74 0.95 -0.23 -0.29
PS Ratio
64.14 18.91 28.75 41.83
PB Ratio
3.61 3.76 2.75 6.63
P/FCF Ratio
-14.56 -10.82 -8.63 -23.34
P/OCF Ratio
-15.52 -14.45 -8.79 -23.63
OCF/S Ratio
-4.13 -1.31 -3.27 -1.77
Debt / Equity Ratio
0.11 0.21 0.04 0.04
Quick Ratio
7.53 4.73 9.04 5.71
Current Ratio
7.53 4.73 8.84 5.62
Asset Turnover
0.05 0.14 0.08 0.12
Interest Coverage
-1.05K -844.54 -916.23 -574.46
Return on Equity
-0.27 -0.37 -0.31 -0.21
Return on Assets
-0.23 -0.26 -0.25 -0.16
Return on Invested Capital
-0.28 -0.33 -0.29 -0.19
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.94 0.97
Net Profit Margin
-4.76 -1.87 -3.24 -1.35
Pretax Profit Margin
-4.76 -1.87 -3.31 -1.38
Operating Profit Margin
-5.56 -2.11 -3.44 -1.38
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-4.59 -1.82 -3.24 -1.34